A Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Two Doses of T3D-959 in Subjects with Mild to Moderate Alzheimer's Disease
Administered By
Awarded By
Contributors
- Welsh-Bohmer, Kathleen Anne Principal Investigator
Start/End
- November 6, 2018 - June 30, 2019